You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prime Chimeric Antigen Receptor T Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Not yet recruiting
  • Lymphoma
  • Chimeric Antigen Receptor
  • (no location specified)
Oct 24, 2023

19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

Recruiting
  • 19 and 22+ B Cell Hematologic Tumors
  • 19 and 20+ B Cell Hematologic Tumors
  • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
  • Wuhan, Hubei, China
    Tongji Hospital
Jan 11, 2023

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

Recruiting
  • Lupus Nephritis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Denver, Colorado
  • +1 more
Jul 7, 2023

Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • LB2102
  • (no location specified)
Jan 10, 2023

Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

Not yet recruiting
  • Advanced Sarcoma
  • NKG2D-CAR memory T cell
  • (no location specified)
Oct 17, 2023

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

Not yet recruiting
  • Neuroendocrine Tumor (NET)
  • Colorectal Cancer (CRC)
  • CHM-2101 CAR-T cells
  • (no location specified)
Sep 20, 2023

Study of Participants Who ReceivedAllogeneic CAR T-Cell Product

Recruiting
  • Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
    • Culver City, California
      Science 37, Inc.
    Apr 10, 2023

    Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

    Recruiting
    • Refractory Multiple Myeloma
    • Relapsed Multiple Myeloma
    • Manufactured Anti-BCMA CAR-T cells
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

    Recruiting
    • B-Cell Lymphoma
    • +4 more
    • 19(T2)28z1xx TRAC T cell
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Feb 24, 2023

    Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

    Not yet recruiting
    • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Nov 28, 2022

    Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

    Not yet recruiting
    • Lymphoma
    • +2 more
    • Web Application
    • San Francisco, California
      University of California, San Francisco
    Oct 4, 2022

    Neuroblastoma Trial (GD2 CAR T cells)

    Not yet recruiting
    • Neuroblastoma
    • GD2 CAR T cells
    • (no location specified)
    Aug 5, 2023

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

    Recruiting
    • Lymphoma
    • +2 more
    • Resistance Training
    • Aerobic Exercise
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 28, 2023

    Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

    Not yet recruiting
    • Lymphomas
    • B-cell Lymphomas
    • Houston, Texas
      The University of Texas M D Anderson Cancer Center
    Mar 6, 2023

    Solid Tumor Trial (HER2-E-CART cells)

    Not yet recruiting
    • Solid Tumor
    • HER2-E-CART cells
    • (no location specified)
    Feb 16, 2023

    Multiple Myeloma Trial in Houston (Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A))

    Not yet recruiting
    • Multiple Myeloma
    • Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A)
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Jan 13, 2023

    Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

    Recruiting
    • Colorectal Cancer
    • +6 more
    • CEA-targeted CAR-T cells
    • Hangzhou, Zhejiang, China
    • +1 more
    Sep 18, 2023

    SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

    Not yet recruiting
    • SLE (Systemic Lupus)
    • CAR T-cell therapy
    • Bangkok, Please Select, Thailand
      King Chulalongkorn Memorial Hospital
    Nov 23, 2023

    Non-hodgkin Lymphoma, Acute Lymphocytic Leukemia Trial in Saint Louis (Duvelisib)

    Recruiting
    • Non-hodgkin Lymphoma
    • Acute Lymphocytic Leukemia
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 30, 2022